{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:41:14Z","timestamp":1761972074465,"version":"build-2065373602"},"reference-count":22,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,10,28]]},"DOI":"10.1248\/bpb.b25-00432","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:07:45Z","timestamp":1761602865000},"page":"1603-1610","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the Potential Inhibitory Effects of Medications for Detrusor Overactivity on Platelet-Activating Factor (PAF)-Induced Mechanical Activity in Guinea Pig Bladder Smooth Muscle"],"prefix":"10.1248","volume":"48","author":[{"given":"Keisuke","family":"Obara","sequence":"first","affiliation":[{"name":"Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2\u20132\u20131 Miyama, Funabashi, Chiba 274\u20138510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futaba","family":"Makino","sequence":"additional","affiliation":[{"name":"Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2\u20132\u20131 Miyama, Funabashi, Chiba 274\u20138510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2\u20132\u20131 Miyama, Funabashi, Chiba 274\u20138510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2\u20132\u20131 Miyama, Funabashi, Chiba 274\u20138510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mako","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2\u20132\u20131 Miyama, Funabashi, Chiba 274\u20138510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kento","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2\u20132\u20131 Miyama, Funabashi, Chiba 274\u20138510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2\u20132\u20131 Miyama, Funabashi, Chiba 274\u20138510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Abrams P. Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. <i>Urology<\/i>, <b>62<\/b> <b>(<\/b>Suppl. 2<b>)<\/b>, 28\u201337, discussion, 40\u201342  (2003).","DOI":"10.1016\/j.urology.2003.09.050"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Madhuvrata P, Singh M, Hasafa Z, Abdel-Fattah M. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis. <i>Eur. Urol.<\/i>, <b>62<\/b>, 816\u2013830 (2012).","DOI":"10.1016\/j.eururo.2012.02.036"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Liu G, Kaneko M, Yoshioka K, Obara K, Tanaka Y. Platelet-activating factor (PAF) strongly enhances contractile mechanical activities in guinea pig and mouse urinary bladder. <i>Sci. Rep.<\/i>, <b>12<\/b>, 2783 (2022).","DOI":"10.1038\/s41598-022-06535-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Obara K, Yoshioka K, Tanaka Y. Effects of platelet-activating factor (PAF) on the mechanical activities of lower urinary tract and genital smooth muscles. <i>Biol. Pharm. Bull.<\/i>, <b>47<\/b>, 1467\u20131476 (2024).","DOI":"10.1248\/bpb.b24-00440"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Obara K, Yoshioka K, Tanaka Y. Platelet-activating factor (PAF) in urinary bladder smooth muscle (UBSM): its novel role as a potential inducer of detrusor overactivity and the mechanisms underlying its effects in enhancing UBSM mechanical activities. <i>Yakugaku Zasshi<\/i>, <b>144<\/b>, 997\u20131007 (2024).","DOI":"10.1248\/yakushi.24-00136"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Madersbacher H, Knoll M. Intravesical application of oxybutynine: mode of action in controlling detrusor hyperreflexia. <i>Preliminary Results. Eur. Urol.<\/i>, <b>28<\/b>, 340\u2013344 (1995).","DOI":"10.1159\/000475078"},{"key":"7","unstructured":"7) Inxight Drugs. \u201cTolterodine.\u201d: &lt;https:\/\/drugs.ncats.io\/drug\/WHE7A56U7K&gt;, accessed 25 May, 2025."},{"key":"8","unstructured":"8) Inxight Drugs. \u201cDesfesoterodine.\u201d: &lt;https:\/\/drugs.ncats.io\/drug\/YU871O78GR&gt;, accessed 25 May, 2025."},{"key":"9","unstructured":"9) Inxight Drugs. \u201cPropiverine hydrochloride.\u201d: &lt;https:\/\/drugs.ncats.io\/drug\/DC4GZD10H3&gt;, accessed 25 May, 2025."},{"key":"10","unstructured":"10) Inxight Drugs. \u201cPropantheline.\u201d: &lt;https:\/\/drugs.ncats.io\/drug\/1306V2B0Q8&gt;, accessed 25 May, 2025."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Doroshyenko O, Fuhr U. Clinical pharmacokinetics and pharmacodynamics of solifenacin. <i>Clin. Pharmacokinet.<\/i>, <b>48<\/b>, 281\u2013302 (2009).","DOI":"10.2165\/00003088-200948050-00001"},{"key":"12","unstructured":"12) Inxight Drugs. \u201cImidafenacin.\u201d: &lt;https:\/\/drugs.ncats.io\/drug\/XJR8Y07LJO&gt;, accessed 25 May, 2025."},{"key":"13","unstructured":"13) An interview form for Bladderon\u00ae tablets was provided by Nippon Shinyaku Co., Ltd. (Kyoto, Japan)."},{"key":"14","unstructured":"14) Inxight Drugs. \u201cUrapidil.\u201d: &lt;https:\/\/drugs.ncats.io\/drug\/A78GF17HJS&gt;, accessed 25 May, 2025."},{"key":"15","unstructured":"15) Inxight Drugs. \u201cClenbuterol.\u201d: &lt;https:\/\/drugs.ncats.io\/drug\/XTZ6AXU7KN&gt;, accessed 25 May, 2025."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Obara K, Takahashi S, Otake M, Fujiwara M, Yamashita M, Murata A, Yoshioka K, Tanaka Y. Platelet-activating factor (PAF) induces strong mechanical activities accompanied by basal tension increases in esophageal and gastric fundus smooth muscles from rat. <i>Biol. Pharm. Bull.<\/i>, <b>48<\/b>, 563\u2013570 (2025).","DOI":"10.1248\/bpb.b25-00125"},{"key":"17","unstructured":"17) Conti M, Setnikar I. Flavoxate, a potent phosphodiesterase inhibitor. <i>Arch. Int. Pharmacodyn. Ther.<\/i>, <b>213<\/b>, 186\u2013189 (1975)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wuest M, Christ T, Hiller N, Braeter M, Ravens U. Effects of three metabolites of propiverine on voltage-dependent L-type calcium currents in human atrial myocytes. <i>Eur. J. Pharmacol.<\/i>, <b>598<\/b>, 94\u201397 (2008).","DOI":"10.1016\/j.ejphar.2008.08.035"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wang N, Yang Y, Wen J, Fan XR, Li J, Xiong B, Zhang J, Zeng B, Shen JW, Chen GL. Molecular determinants for the high-affinity blockade of human ether-\u00e0-go-go-related gene K<sup>+<\/sup> channel by tolterodine. <i>J. Cardiovasc. Pharmacol.<\/i>, <b>80<\/b>, 679\u2013689 (2022).","DOI":"10.1097\/FJC.0000000000001336"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Seo MS, An JR, Jung HS, Jung WK, Choi IW, Na SH, Park H, Bae YM, Park WS. The muscarinic receptor antagonist tolterodine inhibits voltage-dependent K<sup>+<\/sup> channels in rabbit coronary arterial smooth muscle cells. <i>Eur. J. Pharmacol.<\/i>, <b>870<\/b>, 172921 (2020).","DOI":"10.1016\/j.ejphar.2020.172921"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Imai T, Okamoto T, Yamamoto Y, Tanaka H, Koike K, Shigenobu K, Tanaka Y. Effects of different types of K<sup>+<\/sup> channel modulators on the spontaneous myogenic contraction of guinea-pig urinary bladder smooth muscle. <i>Acta Physiol. Scand.<\/i>, <b>173<\/b>, 323\u2013333 (2001).","DOI":"10.1046\/j.1365-201X.2001.00908.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Igawa Y, Schneider T, Yamazaki Y, Tatemichi S, Homma Y, Nishizawa O, Michel MC. Functional investigation of \u03b2-adrenoceptors in human isolated detrusor focusing on the novel selective \u03b23-adrenoceptor agonist KUC-7322. <i>Naunyn Schmiedebergs Arch. Pharmacol.<\/i>, <b>385<\/b>, 759\u2013767 (2012).","DOI":"10.1007\/s00210-012-0763-x"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b25-00432\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:24:06Z","timestamp":1761967446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b25-00432\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00432","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"article-number":"b25-00432"}}